NewGenIvf Group Limited (NIVF)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
In Vitro Fertilization Treatment	4.02M
In Vitro Fertilization Treatment Growth	42.66%
Surrogacy, Ancillary Caring and Other Services	1.11M
Surrogacy, Ancillary Caring and Other Services Growth	-64.34%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Kyrgyzstan	3.12M
Kyrgyzstan Growth	-38.28%
Thailand	1.36M
Thailand Growth	168.37%
Cambodia	621.62K
Cambodia Growth	64.62%
Hong Kong	34.04K